188 related articles for article (PubMed ID: 11552228)
21. Efficacy and toxicity of nonpegylated liposomal doxorubicin in breast cancer.
Stavridi F; Palmieri C
Expert Rev Anticancer Ther; 2008 Dec; 8(12):1859-69. PubMed ID: 19046106
[TBL] [Abstract][Full Text] [Related]
22. Pegylated liposomal doxorubicin in combination with vinorelbine as salvage treatment in pretreated patients with advanced breast cancer: a multicentre phase II study.
Ardavanis A; Mavroudis D; Kalbakis K; Malamos N; Syrigos K; Vamvakas L; Kotsakis A; Kentepozidis N; Kouroussis C; Agelaki S; Georgoulias V;
Cancer Chemother Pharmacol; 2006 Dec; 58(6):742-8. PubMed ID: 16718470
[TBL] [Abstract][Full Text] [Related]
23. From conventional to stealth liposomes: a new frontier in cancer chemotherapy.
Cattel L; Ceruti M; Dosio F
Tumori; 2003; 89(3):237-49. PubMed ID: 12908776
[TBL] [Abstract][Full Text] [Related]
24. Liposomal anthracyclines: adjuvant and neoadjuvant therapy for breast cancer.
Campos S
Oncologist; 2003; 8 Suppl 2():10-6. PubMed ID: 13679591
[TBL] [Abstract][Full Text] [Related]
25. Cardiac safety of liposomal anthracyclines.
Safra T
Oncologist; 2003; 8 Suppl 2():17-24. PubMed ID: 13679592
[TBL] [Abstract][Full Text] [Related]
26. [Cardiac tolerance of the combination paclitaxel-anthracyclines in the context of the management of cancer of the breast].
Ferrero JM; Magné N; Foa C; Largillier R; Namer M
Bull Cancer; 2003 Mar; 90(3):219-26. PubMed ID: 12801824
[TBL] [Abstract][Full Text] [Related]
27. Caelyx/Doxil for the treatment of metastatic ovarian and breast cancer.
Tejada-Berges T; Granai CO; Gordinier M; Gajewski W
Expert Rev Anticancer Ther; 2002 Apr; 2(2):143-50. PubMed ID: 12113236
[TBL] [Abstract][Full Text] [Related]
28. Liposomal encapsulated anthracyclines: new therapeutic horizons.
Muggia FM
Curr Oncol Rep; 2001 Mar; 3(2):156-62. PubMed ID: 11177748
[TBL] [Abstract][Full Text] [Related]
29. Chemotherapy and cardiotoxicity in older breast cancer patients: a population-based study.
Doyle JJ; Neugut AI; Jacobson JS; Grann VR; Hershman DL
J Clin Oncol; 2005 Dec; 23(34):8597-605. PubMed ID: 16314622
[TBL] [Abstract][Full Text] [Related]
30. Multicenter phase II study of pegylated liposomal doxorubicin in combination with vinorelbine as first-line treatment in elderly patients with metastatic breast cancer.
Mlineritsch B; Schabel-Moser R; Andel J; Fridrik M; Moik M; Mayer P; Russ G; Rass C; Greil R;
Onkologie; 2009 Feb; 32(1-2):18-24. PubMed ID: 19209014
[TBL] [Abstract][Full Text] [Related]
31. Five-day infusion of fluorouracil and vinorelbine for advanced breast cancer patients treated previously with anthracyclines.
Pieńkowski T; Jagiello-Gruszfeld A
Int J Clin Pharmacol Res; 2001; 21(3-4):111-7. PubMed ID: 12067140
[TBL] [Abstract][Full Text] [Related]
32. Paclitaxel for treating KS.
Proj Inf Perspect; 1997 Nov; (23):15. PubMed ID: 11365372
[TBL] [Abstract][Full Text] [Related]
33. First line therapy with paclitaxel (Taxol) and pegylated liposomal doxorubicin (Caelyx) in patients with metastatic breast cancer: a multicentre phase II study.
Vorobiof DA; Rapoport BL; Chasen MR; Slabber C; McMichael G; Eek R; Mohammed C
Breast; 2004 Jun; 13(3):219-26. PubMed ID: 15177425
[TBL] [Abstract][Full Text] [Related]
34. Evolving approaches to metastatic breast cancer previously treated with anthracyclines and taxanes.
Murphy CG; Seidman AD
Clin Breast Cancer; 2009 Jun; 9 Suppl 2():S58-65. PubMed ID: 19596644
[TBL] [Abstract][Full Text] [Related]
35. Advantages of liposomal delivery systems for anthracyclines.
Allen TM; Martin FJ
Semin Oncol; 2004 Dec; 31(6 Suppl 13):5-15. PubMed ID: 15717735
[TBL] [Abstract][Full Text] [Related]
36. Use of liposomal anthracyclines in Kaposi's sarcoma.
Krown SE; Northfelt DW; Osoba D; Stewart JS
Semin Oncol; 2004 Dec; 31(6 Suppl 13):36-52. PubMed ID: 15717737
[TBL] [Abstract][Full Text] [Related]
37. Liposomal anthracycline administration and toxicity management: a nursing perspective.
Wood LS
Semin Oncol; 2004 Dec; 31(6 Suppl 13):182-90. PubMed ID: 15717743
[TBL] [Abstract][Full Text] [Related]
38. Pegylated liposomal doxorubicin in the treatment of breast cancer.
O'Shaughnessy JA
Clin Breast Cancer; 2003 Dec; 4(5):318-28. PubMed ID: 14715106
[TBL] [Abstract][Full Text] [Related]
39. Extravasation of liposomal daunorubicin in patients with AIDS-associated Kaposi's sarcoma: a report of four cases.
Cabriales S; Bresnahan J; Testa D; Espina BM; Scadden DT; Ross M; Gill PS
Oncol Nurs Forum; 1998; 25(1):67-70. PubMed ID: 9460774
[TBL] [Abstract][Full Text] [Related]
40. [Administration of liposomal preparation of DaunoXome for breast cancer in patients with poor prognosis].
Darskaia EI; Zubarovskaia LS; Afanas'ev BV
Vopr Onkol; 1999; 45(4):440-4. PubMed ID: 10532108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
